Biochemistry and Pharmacology - Research Publications

Permanent URI for this collection

http://hdl.handle.net/11343/214

Filters

2019 1
1
Reset filters

Settings
Statistics
Citations
Author: Kazemi, Mohsen × Author: Rouiller, Isabelle × Start date: 2011 × End date: 2019 ×

Search Results

Now showing 1 - 1 of 1
  • Item
    No Preview Available
    An Asymmetric Opening of HIV-1 Envelope Mediates Antibody-Dependent Cellular Cytotoxicity
    Alsahafi, N ; Bakouche, N ; Kazemi, M ; Richard, J ; Ding, S ; Bhattacharyya, S ; Das, D ; Anand, SP ; Prevost, J ; Tolbert, WD ; Lu, H ; Medjahed, H ; Gendron-Lepage, G ; Delgado, GGO ; Kirk, S ; Melillo, B ; Mothes, W ; Sodroski, J ; Smith, AB ; Kaufmann, DE ; Wu, X ; Pazgier, M ; Rouiller, I ; Finzi, A ; Munro, JB (CELL PRESS, 2019-04-10)
    The HIV-1 envelope glycoprotein (Env) (gp120-gp41)3 is the target for neutralizing antibodies and antibody-dependent cellular cytotoxicity (ADCC). HIV-1 Env is flexible, sampling different conformational states. Before engaging CD4, Env adopts a closed conformation (State 1) that is largely antibody resistant. CD4 binding induces an intermediate state (State 2), followed by an open conformation (State 3) that is susceptible to engagement by antibodies that recognize otherwise occluded epitopes. We investigate conformational changes in Env that induce ADCC in the presence of a small-molecule CD4-mimetic compound (CD4mc). We uncover an asymmetric Env conformation (State 2A) recognized by antibodies targeting the conserved gp120 inner domain and mediating ADCC. Sera from HIV+ individuals contain these antibodies, which can stabilize Env State 2A in combination with CD4mc. Additionally, triggering State 2A on HIV-infected primary CD4+ T cells exposes epitopes that induce ADCC. Strategies that induce this Env conformation may represent approaches to fight HIV-1 infection.